Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells.

MLA

Arafeh, Rand, et al. “Author Correction: Combined Inhibition of MEK and Nuclear ERK Translocation Has Synergistic Antitumor Activity in Melanoma Cells.” Scientific Reports, vol. 9, no. 1, Mar. 2019, p. 1. EBSCOhost, https://doi.org/10.1038/s41598-018-37931-7.

APA

Arafeh, R., Flores, K., Keren-Paz, A., Maik-Rachline, G., Gutkind, N., Rosenberg, S., Seger, R., & Samuels, Y. (2019). Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells. Scientific Reports, 9(1), 1. https://doi.org/10.1038/s41598-018-37931-7

Chicago

Arafeh, Rand, Karen Flores, Alona Keren-Paz, Galia Maik-Rachline, Naomi Gutkind, Steven Rosenberg, Rony Seger, and Yardena Samuels. 2019. “Author Correction: Combined Inhibition of MEK and Nuclear ERK Translocation Has Synergistic Antitumor Activity in Melanoma Cells.” Scientific Reports 9 (1): 1. doi:10.1038/s41598-018-37931-7.